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In radiation accidents, it is common that only several parts of the body are exposed 
to radiation. As a consequence there is a mixture of exposed and unexposed 
lymphocytes in peripheral blood cells of the samples. This phenomenon will cause 
the dose value estimated using the exposed lymphocytes to be lower than the actual 
dose. In this study, an assessment of partial body exposures using micronucleus 
assay by estimating the partial body dose and fraction of irradiated blood was 
conducted. An optimal D0 value also has been determined in this study to estimate 
the fraction of irradiated cells. Peripheral blood lymphocytes (PBLs) from three 
healthy donors were irradiated in vitro with 2 Gy of X-rays. Partial radiation 
exposure was simulated by mixing the irradiated and non-irradiated blood in 
different proportions. The proportions of mixtures of blood samples irradiated in 
vitro were 5, 10, 15, 20, and 30 %. Blood samples were then cultured and harvested 
based on micronuclei assay protocol. At least 2000 binucleated cells with well-
preserved cytoplasm were scored for the MN frequency. Dose Estimate 5.1 software 
was used to calculate the dispersion index (σ2/y) and normalized unit of this index 
(U) in each proportion of bloods. The fractions of irradiated cells were calculated 
with CABAS (Chromosomal Aberration Calculation Software) for several different 
D0 values (2.7; 3.8; 5.4). The results showed that D0 value at 5.4 gave the closest 
results to the actual proportion of irradiated bloods, while for the dose estimation 
the estimated doses value from all proportions in all donors were higher than the 
actual dose. The factor that may cause this phenomenon was that the dose response 
calibration curve used to predict the radiation dose was not constructed in the 
laboratory used. Overall it can be concluded that a biodosimetry using MN assay 
can be used to estimate the radiation dose in partial body exposure. In order to 
establish a biodosimetry using MN analysis the dose-response calibration curve MN 
analysis should be constructed first in the laboratory used.  
 
© 2017 Atom Indonesia. All rights reserved 
 
 
INTRODUCTION 
 
The radiation doses absorbed and distributed 
into the bodies of radiation accident casualties are 
important to guide immediate medical treatment, 
further health care, and prognosis of exposure 
casualties [1]. In radiation accidents, the exposure 
mostly occurs only to part of the body and as a 
result there is a mixture of exposed and unexposed 
lymphocytes in peripheral blood samples [2].    
                                                 
 Corresponding author. 
   E-mail address: dhani02@batan.go.id 
   DOI: https://doi.org/10.17146/aij.2017.405 
Since the exposed and unexposed lymphocytes             
are mixed, the dose received by the exposed 
lymphocytes and the dose delivered locally could be 
underestimated [3]. Discrimination between victims 
that are exposed for the whole body with those that 
are exposed partially is important as they will have 
different clinical outcomes, and it affects the 
medical care to treat them [4]. Until now, there are 
two mathematical models that have been developed 
to assess the dose according to the fraction of 
exposed lymphocytes, i.e., Qdr and Dolphin’s 
models. Both models have been validated in vitro by 
mixing irradiated and unirradiated blood in different 
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proportions and have also been tested in vivo in 
accident situations, with promising results [3,5]. 
Several studies have been conducted to 
estimate the radiation dose that is received partially 
by radiotherapy patients. Silva-Barbosa et al., study 
showed that chromosomal aberrations and 
micronuclei (MN) quantification in lymphocytes 
from peripheral blood of cervical uterine cancer 
patients before and after receiving 0.08 Gy and                
1.8 Gy was a potentially advantageous methodology 
of dose assessment especially in partial body 
exposure to ionizing radiation [6]. Another study, 
conducted by Senthamizhchelvan et al., revealed 
that biological dosimetry using micronuclei (MN) 
assays was applicable for dose estimation in 
therapeutic irradiation of cancer patients in acute 
high dose partial body irradiation [7]. 
Biological dosimetry (biodosimetry) is an 
investigation of biological effects (bioindicators) 
induced by radiation in order to correlate them with 
the radiation dose. Scoring of unstable chromosome 
aberrations (dicentrics, rings, and fragments) is 
considered as the most reliable method for 
evaluating individual exposure, and is specific to 
radiation exposure [8-10]. Another well known 
bioindicator of radiation damage is MN in 
peripheral blood lymphocytes [11]. Micronucleus 
are chromosome fragments that lag behind during 
anaphase and are not included in the main nucleus 
during telophase. They appear as small nuclei and 
can be identified during cell binucleation in the 
division of mitogen-activated human lymphocytes 
by blocking cytokinesis [5-7]. 
In this study, an assessment of partial-body 
exposures using MN assay was conducted, 
including the estimations of partial-body dose and 
fraction of irradiated blood. An optimal D0 value has 
also been determined in this study to estimate the 
fraction of irradiated cells. 
 
 
EXPERIMENTAL METHODS 
 
Blood sampling, irradiation process and 
simulated partial-body irradiation  
 
Since the focus of this study was to estimate 
the partial-body dose exposures using MN assay, we 
only used three samples that consisted of one male 
and two females without history of smoking habit 
and ionizing radiation exposure beyond routine 
diagnostic exposures. The reason that both male and 
female samples were used in this study was that it 
was decided that it was necessary to know whether 
the gender factor influenced the predicted dose 
value in partial-body exposure. Peripheral blood 
samples from all donors were collected in 
heparinized vacutainers. The characteristics of the 
donors are presented in Table 1. The blood samples 
were irradiated in vitro at the Secondary Standard 
Dosimetry Laboratory at Center for Radiation 
Safety Technology and Metrology, National Nuclear 
Energy Agency of Indonesia. Blood samples were 
exposed to X-ray (YXLON MG325) at 122 kV 
using additional filters of 1.66 mm Cu and 1 mm Al 
with an HVL of 2.52 mm Cu at 2 Gy with a dose 
rate 0.17 Gy/min. The radiation dose used in this 
study was 2 Gy because this is commonly used as    
a radiotherapy dose fractionation. After irradiation, 
the blood samples were maintained at 37 °C for one 
hour to enable repair of chromosomal damages.    
To simulate partial-body exposures the irradiated 
blood was mixed with non-irradiated blood to final 
proportions of 5, 10, 15, 20, and 30 %. 
 
Table 1.  Characteristics of the donor samples. 
 
Gender Age  
Smoking Habit 
(yes; no) 
X-ray medical 
diagnostics 
within 
the last year 
(yes; no) 
Male 30 No  No 
Female 43 & 52 Yes (0) No (2) Yes (0) No (2) 
 
 
Calibration of irradiation facilities 
 
The measurement of air kinetic energy 
released in material (kerma) was done before the    
X-ray machines were applied for irradiating blood 
samples using an NE Technology type 2570 Farmer 
dosimeter and a type 2571 ionization chamber. 
Measurement of air kerma was done in the air at the 
source-to-sample-center distance of 100 cm, and the 
radiation field was 10 cm. The air kerma from X-ray 
track was calculated using the equation given in 
IAEA Technical Reports Series No. 277. 
 
 
Blood culture 
 
Blood cultures (0.5 mL) were set up in 
Roswell Park Memorial Institute (RPMI 1640) 
culture medium supplemented with HEPES and     
L-Glutamine, 15 % Fetal Bovine Serum (FBS), 
Penicillin-Streptomycin, and Phytohaemagglutinin 
(PHA). The cultures were maintained in a 5 % 
humidified CO2 incubator at 37 °C for 72 h.      
After incubation for 44 h, 15 µl of cytochalasin B 
(Sigma-Aldrich) solution in DMSO (Sigma-Aldrich) 
was added to cultures, and cultivation was continued 
for another 24 h. The cultures were then treated with 
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cold hypotonic solution (0.075 M KCl) to lyse red 
blood. The fixative consisting of methanol:acetic 
acid (10:1) diluted with Ringer’s solution (NaCl, 
KCl, CaCl2) should be added to replace the 
hypotonic solution. Then, the supernatant was 
washed with fixative solution twice or three times 
until the cell suspension is clear. The cells were then 
resuspended gently and the suspension dropped onto 
clean glass slides and allowed to dry. The slides 
were then stained with 4 % Giemsa's solution in a 
potassium phosphate buffer (pH 7.3) and allowed to 
dry overnight. The slides were mounted with cover 
slip and allowed to dry completely before scoring. 
The slides were then analyzed, and identification of 
MN was conducted according to the scoring criteria 
in IAEA publication [5]. At least 2000 binucleated 
cells with well-preserved cytoplasm were scored for 
the MN frequency. 
 
 
Statistical Analysis 
 
The dispersion index (σ2/y) and also the 
normalized unit of this index (U) were calculated  
for each proportion of blood using Dose Estimate 
5.1 software. The fractions of irradiated cells were 
also calculated for the estimated dose (D) using 
several different D0 value (2.7; 3.8; 5.4) using 
Chromosome Aberration Calculation Software 
(CABAS) version 2.0. 
 
 
RESULTS AND DISCUSSION 
 
The MN frequencies and distributions in all 
proportions of irradiated blood tested were 
presented at Table 2. It was clearly seen that in all 
proportion of irradiated bloods the u values were 
significant overdispersion (u > 1.96). Value of u 
varies from 7.93 to 26.2. In dicentric analysis it was 
well known that to determine the type of radiation 
exposure can be seen from u value evaluation.                  
In case of whole body exposure the u value 
commonly follow Poisson distribution. A significant 
overdispersion is suggestive of partial irradiation for 
dicentric analysis and can be used to differentiate 
the homogeneously exposed samples from 
heterogeneously exposed samples [12]. In contrast 
for MNs assays the u values commonly overdispere, 
as it can be seen in table 2 even at control group 
(100 %) the u value still overdispere. The proportion 
of irradiated cells and estimated dose (D) with 
several different D0 values (2.7; 3.8; 5.4) using 
CABAS 2.0 were presented at Table 3. It can be 
seen that D0 value at 5.4 gave a results closest to the 
real proportion of irradiated bloods (Fig. 1).
 
Table 2.  The MN frequencies and distributions in all proportions of irradiated blood. 
 
Donor 
(Age, Sex) 
% 
Irradiated 
Bloods 
BNC MN 
Distribution  of MN 
Y ± SE σ2/y ± SE U 
0 1 2 3 4 5 
1 (30, Male) 
5 % 2160 35 2135 18 5 1 1 0 0.016±0.005 1.780±0.030 26.200 
10 % 2153 47 2114 33 4 2 0 0 0.022±0.004 1.400±0.030 13.400 
15 % 2157 82 2089 55 12 1 0 0 0.038±0.005 1.330±0.030 10.900 
20 % 2200 105 2118 64 14 3 1 0 0.048±0.008 1.510±0.030 16.800 
30 % 2204 171 2080 88 27 7 2 0 0.078±0.010 1.620±0.030 20.800 
100 % 2037 590 1599 313 102 19 4 0 0.290±0.016 1.330±0.031 10.600 
2 (43, Female) 
5 % 2209 60 2161 39 7 1 1 0 0.027±0.006 1.510±0.030 17.000 
10 % 2189 83 2122 56 8 1 2 0 0.038±0.006 1.520±0.030 17.200 
15 % 2171 100 2088 69 11 3 0 0 0.046±0.007 1.350±0.030 11.700 
20 % 2198 93 2123 61 11 2 1 0 0.042±0.006 1.450±0.030 15.100 
30 % 2298 152 2175 98 21 4 0 0 0.066±0.007 1.370±0.029 12.500 
100 % 2054 597 1612 317 101 19 4 1 0.291±0.016 1.350±0.031 11.300 
3 (52, Female) 
5 % 2157 76 2097 47 10 3 0 0 0.035±0.006 1.470±0.030 15.400 
10 % 2173 96 2099 58 11 4 1 0 0.044±0.008 1.560±0.030 18.600 
15 % 2140 97 2065 58 13 3 1 0 0.045±0.008 1.530±0.030 17.500 
20 % 2128 115 2029 84 14 1 0 0 0.054±0.006 1.240±0.031 7.930 
30 % 2227 162 2100 98 24 4 1 0 0.073±0.009 1.450±0.030 14.900 
100 % 2077 550 1664 304 86 18 5 0 0.265±0.015 1.350±0.031 11.400 
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Table 3.  Predicted fraction of irradiated cells and estimated dose (D) with several different D0 values (2.7; 3.8; 5.4). 
 
Donor 
(Age, Sex) 
% 
Irradiated 
Bloods 
D0 = 2.7 D0 = 3.8 D0 = 5.4 
Estimated % 
Irradiated 
Estimated Partial 
Dose (Gy) 
Estimated % 
Irradiated 
Estimated Partial 
Dose (Gy) 
Estimated % 
Irradiated 
Estimated Partial 
Dose (Gy) 
1 (30, Male) 
5 % 10.16 4.3237 6.66 4.3237 4.86 4.3237 
10 % 14.27 2.8037 10.99 2.8037 9.04 2.8037 
15 % 23.27 2.8037 18.36 2.8037 15.32 2.8037 
20 % 26.48 3.4517 19.96 3.4517 16.02 3.4517 
30 % 37.33 4.1589 27.66 4.1589 21.69 4.1589 
 
2 (43, Female) 
5 % 16.74 3.1624 12.55 3.1624 10.10 3.1624 
10 % 22.56 3.0624 17.36 3.0624 14.22 3.0624 
15 % 27.52 2.7504 22.07 2.7504 18.62 2.7504 
20 % 24.62 3.1127 18.98 3.1127 15.55 3.1127 
30 % 35.34 3.0624 28.28 3.0624 23.72 3.0624 
3 (52, Female) 
5 % 20.76 3.3090 15.55 3.3090 12.47 3.3090 
10 % 24.68 3.5909 18.27 3.5909 14.47 3.5909 
15 % 25.26 3.5449 18.81 3.5449 14.97 3.5449 
20 % 33.48 2.3592 28.13 2.3592 24.58 2.3592 
30 % 36.82 3.4045 28.85 3.4045 23.74 3.4045 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Estimate of percentage (%) irradiated compared to actual 
values irradiated using three different D0 values, namely 2.7 
(triangles), 3.8 (circles) and 5.4 (squares). 
 
 
Even though the D0 value of 5.4 gave a better 
results compared to others D0 values, the predicted 
proportions of irradiated cells are still       
inaccurate. The factor that may have caused this 
phenomenon was the dose-response calibration 
curve used to predict the fraction of irradiated    
cells. In this study the dose-response calibration 
curve was from Pajic et al., [13]. Since the 
laboratory where this study took place did not     
have its own dose-response calibration curve for 
MN, a calibration curve from another study is used 
here. Inaccuracy in fraction estimation was also    
reported using several D0 value in the dicentric 
assay [14]. 
IAEA recommended that laboratories 
performing biological dose assessment using 
cytogenetic analysis should obtain their own     
dose-response calibration curve for different types 
and energies of radiation [5]. For that reason,       
and to obtain more accurate dose prediction        
(and prediction of proportion of irradiated cells in 
the case of partial body exposure) the laboratory     
used in this study now develops the dose-response 
calibration curve for micronuclei analysis.            
For dose estimation, the estimated doses             
value from all proportions in all donors was higher 
compared to the actual dose of 2 Gy (Fig. 2).          
A factor that may contribute to this result             
was the dose-response calibration curve used for 
dose estimation not being constructed in the 
laboratory. From the results of this study, it was 
clear that the radiation dose-response calibration 
curve for the MN analysis should be produced in the 
same laboratory. The laboratory previously 
successfully developed a dose-response calibration 
curve for dicentric analysis induced by gamma rays 
[15]. In order to establish a biodosimetry using MN 
analysis, the dose-response calibration curve for 
MN analysis must be constructed first. 
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Fig. 2.  Estimate of radiation dose values for all proportions of 
irradiated bloods from three different donors. The dashed line is 
the actual radiation dose of 2 Gy.  
 
The results show that the induced MN 
freuencies are proportional to the percentage of 
irradiated lymphocytes. For example, the total 
number of MN for 30 % at donor 1 was 171      
while for 100 % was 590. It can also be seen that 
most of binucleated cells contained a single MN. 
There are inter-individual differences among 
subjects that are influenced by different        
mutagen sensitivity and DNA repair capacity.          
It was known that MN frequency in females       
tends to be higher relative to males by a factor 
approximately 1.4. Researchers suspect that the 
higher MN frequency in females correlated         
with greater tendency of the inactive X-chromosome 
to be lost as an MN relative to other     
chromosomes, and to the fact that females have    
two copies of the chromosome compared to        
only one in males [16,17]. 
A study conducted by Jones et al. [18] 
showed that in 19.9 % of the cells scored at least 
one sex chromatin-positive MN was present. 
Another study by Hando et al. [19] found              
that X-chromosomes present in 72.2 % of the MN 
scored and that a significant increase occurred with 
age in the number of MNs containing an                
X-chromosome. The increase of MN with age          
is due to a combination of several factors, namely: 
(i) the cumulative effect of acquired mutations                   
in genes involved in DNA repair, and: (ii)       
numerical and structural aberrations in 
chromosomes caused by exposure to endogenous 
genotoxins, inadequate nutrition, exposure to 
environmental or occupational genotoxins, and a 
wide range of unhealthy lifestyle factors [16]. 
Interestingly, from our results the total MN in 
the male was higher compared to average of total 
MN from the two females. Age also did not exhibit 
influence in our study as can be seen that the total 
MN in donor 3 was lower compared to other donors. 
Since in this study the number of sample donors 
only consisted of three people, it is possible that 
influence of sex and age to total MN cannot be seen 
from this study. Further studies should be conducted 
to verify the effect of sex and age factors to number 
of MN in human peripheral lymphocytes.            
Here an evaluation of micronuclei for estimating the 
dose of radiation to lymphocytes is described. 
Micronuclei are only expressed in cells that proceed 
to complete nuclear division. This assay has 
emerged as one of the preferred methods for 
assessing chromosomal damage because they enable 
both chromosome loss and chromosome breakage   
to be measured reliably. 
Moreover, this technique is useful for 
determining irradiation dosage by examining a large 
number of binucleated cells faster and using  
simpler techniques than chromosome aberrations. 
The technique is very easy to use when a large 
number of cells must be examined for routine 
monitoring of workers exposed to radiation    
[20,21] as MN is a good tool for cancer risk 
prediction as well as for studying genotoxicity and 
cytotoxicity as well as studies on genomic damage 
by chemicals in general [22].  
 
 
CONCLUSION 
 
Overall, it can be concluded from this study 
that biodosimetry using MN assay can be used to 
estimate the radiation dose in  partial body 
exposure. However, it was not possible to 
distinguish between partial or total body exposures 
using Poisson or overdispersion distribution as the 
basis when conducting biodosimetry using MN 
assay. An optimal D0 value was also calculated in 
this study and it can be seen that from this study  
that a D0 value of 5.4 gave more accurate results 
compared with 2.7 and 3.8. To obtain more  
accurate results the laboratory used should  
construct the dose-response calibration curve for 
MN analysis in further studies.  
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